SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CBUS

Cibus, Inc. (NASDAQ:CBUS)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$1.13+$0.04 (+3.67%)
 
Market cap
$86.4M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 20, 2017
Website
Market Cap$86.36M-7.4%
Revenue (ttm)$4.53M+19.5%
Net Income-$96.59M+18.8%
EPS-$1.50+53.4%
Shares Out76.43M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume148,181
Open$1.08
Previous Close$1.09
Day's Range$1.02 - $1.14
52-Week Range$1.02 - $4.19
Beta1.64
AnalystsBuy
Price Target$11.50(+917.70%)
Earnings DateMar 16, 2027
+3.67% (1D)
No price history available.

About CBUS

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Address
6455 Nancy Ridge Drive, San Diego, CA, 92121, US
Market Cap
86 million
Employees
118
Industrial Classification
Biotechnology
Financial Health Score
Distressed
From CBUS’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
+3.67%
5 Days
-5.83%
1 Month
-19.29%
6 Months
-19.86%
1 Year
-7.38%

$CBUS stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CBUS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CBUS's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CBUS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New CBUS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CBUS from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CBUS

VTIVanguard Morningstar Total Stock Market ETF$2.58M
VXFVanguard Extended Market ETF$946.43K
IWCiShares Micro-Cap ETF$205.14K
KROPGlobal X AgTech & Food Innovation ETF$41.87K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CBUS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
85
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

KROPGlobal X AgTech & Food Innovation ETF0.27%

Weight is the stock’s share of each fund’s holdings.